Literature DB >> 2498976

Performance characteristics of a blood cholesterol measuring instrument used in screening programs.

R C Lefebvre1, T H Lasater, S M McKinlay, K M Gans, N Walker, R A Carleton.   

Abstract

Four experiments were conducted to assess the precision and accuracy of the Boehringer Mannheim Diagnostics Reflotron, an instrument that is being adopted by many public health groups to conduct blood cholesterol screening programs. Our study is one of the first to evaluate and document the instrument's performance characteristics. Successive generations of reagent tabs supplied by the manufacturer were tested against a reference laboratory method standardized by the Centers for Disease Control. Three of the experiments also compared two or more Reflotrons to assess intermachine reliability. The Reflotron analyzer provided precise blood cholesterol measurements both in repeated tests and among instruments. The accuracy of the method varied across reagent lots, with an average negative bias of 21.05 milligrams per deciliter (mg per dl), decreasing steadily to a negative bias of 4.07 mg per dl. Reliability between and within analyzers was high. The data provide support for the use of the instrument in blood cholesterol screening efforts, yet signal the need for attention to quality control procedures, both by the manufacturer and operators, to ensure the validity and accuracy of the results.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2498976      PMCID: PMC1579928     

Source DB:  PubMed          Journal:  Public Health Rep        ISSN: 0033-3549            Impact factor:   2.792


  5 in total

1.  Rapid measurement of blood cholesterol: evaluation of a new instrument.

Authors:  T M Lasater; R C Lefebvre; A R Assaf; A L Saritelli; R A Carleton
Journal:  Am J Prev Med       Date:  1987 Nov-Dec       Impact factor: 5.043

2.  Change in public perspective on cholesterol and heart disease. Results from two national surveys.

Authors:  B Schucker; K Bailey; J T Heimbach; M E Mattson; J T Wittes; C M Haines; D J Gordon; J A Cutler; V S Keating; R S Goor
Journal:  JAMA       Date:  1987-12-25       Impact factor: 56.272

3.  Prevention of coronary heart disease--propaganda, promises, problems, and prospects.

Authors:  M F Oliver
Journal:  Circulation       Date:  1986-01       Impact factor: 29.690

4.  Population screening for cholesterol determination. A pilot study.

Authors:  E L Wynder; F Field; N J Haley
Journal:  JAMA       Date:  1986-11-28       Impact factor: 56.272

5.  Community intervention to lower blood cholesterol: the "Know Your Cholesterol" campaign in Pawtucket, Rhode Island.

Authors:  R C Lefebvre; G S Peterson; S A McGraw; T M Lasater; L Sennett; L Kendall; R A Carleton
Journal:  Health Educ Q       Date:  1986
  5 in total
  2 in total

1.  Performance of the Reflotron in Massachusetts' Model System for Blood Cholesterol Screening Program.

Authors:  S Havas; R Bishop; L Koumjian; J Reisman; S Wozenski
Journal:  Am J Public Health       Date:  1992-03       Impact factor: 9.308

2.  Training health professionals and lay volunteers to deliver cholesterol screening and education programs.

Authors:  L A Linnan; K M Gans; M L Hixson; E Mendes; H Longpre; R A Carleton
Journal:  Public Health Rep       Date:  1990 Nov-Dec       Impact factor: 2.792

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.